The Role of Cancer-Associated Fibroblasts in Hepatocellular Carcinoma and the Value of Traditional Chinese Medicine Treatment

被引:26
|
作者
Jia, Wentao [1 ]
Liang, Shufang [2 ]
Cheng, Binbin [1 ]
Ling, Changquan [1 ]
机构
[1] Naval Med Univ, Sch Tradit Chinese Med, Shanghai, Peoples R China
[2] Navy Med Univ, Changhai Hosp, Dept Tradit Chinese Med, Shanghai, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2021年 / 11卷
基金
中国国家自然科学基金;
关键词
cancer-associated fibroblasts (CAFs); traditional Chinese medicine; hepatocellular carcinoma (HCC); stromal cell; tumor recurrence; HEPATIC STELLATE CELLS; GINKGO-BILOBA EXTRACT; ATTENUATES LIVER FIBROSIS; TISSUE GROWTH-FACTOR; GENE-EXPRESSION; LIPID DROPLETS; PPAR-GAMMA; STEM-CELLS; RAT-LIVER; KAPPA-B;
D O I
10.3389/fonc.2021.763519
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Invasion and metastasis are the main reasons for the high mortality of liver cancer, which involve the interaction of tumor stromal cells and malignant cells. Cancer-associated fibroblasts (CAFs) are one of the major constituents of tumor stromal cells affecting tumor growth, invasion, and metastasis. The heterogeneous properties and sources of CAFs make both tumor-supporting and tumor-suppression effects possible. The mechanisms for CAFs in supporting hepatocellular carcinoma (HCC) progression can be categorized into upregulated aggressiveness and stemness, transformed metabolism toward glycolysis and glutamine reductive carboxylation, polarized tumor immunity toward immune escape of HCC cells, and increased angiogenesis. The tumor-suppressive effect of fibroblasts highlights the functional heterogenicity of CAF populations and provides new insights into tumor-stromal interplay mechanisms. In this review, we introduced several key inflammatory signaling pathways in the transformation of CAFs from normal stromal cells and the heterogeneous biofunctions of activated CAFs. In view of the pleiotropic regulation properties of traditional Chinese medicine (TCM) and heterogeneous effects of CAFs, we also introduced the application and values of TCM in the treatment of HCC through targeting CAFs.
引用
收藏
页数:16
相关论文
共 50 条
  • [31] The Role of Cancer-Associated Fibroblasts in Ovarian Cancer
    Zhang, Mo
    Chen, Zhixian
    Wang, Yan
    Zhao, Hongbo
    Du, Yan
    CANCERS, 2022, 14 (11)
  • [32] Role of cancer-associated fibroblasts in the esophageal squamous cell carcinoma microenvironment
    Higashino, Nobuhide
    Okamoto, Maiko
    Doi, Masayuki
    Ikeda, Chihoko
    Kodaira, Himiko
    Hosono, Masayoshi
    Ichihara, Yumi
    Nishio, Mari
    Shigeoka, Manabu
    Koma, Yuichiro
    Yokozaki, Hiroshi
    CANCER SCIENCE, 2018, 109 : 699 - 699
  • [33] Emerging role of cancer-associated fibroblasts in esophageal squamous cell carcinoma
    Li, Wenqing
    Xu, Tianqi
    Jin, Hai
    Li, Mingyang
    Jia, Qingge
    PATHOLOGY RESEARCH AND PRACTICE, 2024, 253
  • [34] The role of cancer-associated fibroblasts in esophageal cancer
    Jiangfeng Wang
    Guangyu Zhang
    Jianbo Wang
    Lu Wang
    Xiaochen Huang
    Yufeng Cheng
    Journal of Translational Medicine, 14
  • [35] An Overview of Traditional Chinese Medicine in the Treatment After Radical Resection of Hepatocellular Carcinoma
    Peng, Yichen
    Wu, Xia
    Zhang, Yurong
    Yin, Yue
    Chen, Xianglin
    Zheng, Ding
    Wang, Jing
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2023, 10 : 2305 - 2321
  • [36] Cancer-associated fibroblasts in papillary thyroid carcinoma
    Li Zhu
    Xuemei Zhang
    Shuhan Zhang
    Qicheng Zhang
    Limin Cao
    Yujie Zhang
    Dan Wang
    Xiaohui Liang
    Weiming Wu
    Shuanghu Wu
    Ruoyu Jiang
    Yue Liu
    Xue Zhao
    Guiming Zhou
    Ke Xu
    Zhaowei Meng
    Clinical and Experimental Medicine, 2023, 23 : 2209 - 2220
  • [37] Identification of cancer-associated fibroblasts signature for predicting the prognosis and immunotherapy response in hepatocellular carcinoma
    Ye, Jianzhong
    Tian, Wen
    Zheng, Bigeng
    Zeng, Tao
    MEDICINE, 2023, 102 (45) : E35938
  • [38] Cancer-associated fibroblasts in papillary thyroid carcinoma
    Zhu, Li
    Zhang, Xuemei
    Zhang, Shuhan
    Zhang, Qicheng
    Cao, Limin
    Zhang, Yujie
    Wang, Dan
    Liang, Xiaohui
    Wu, Weiming
    Wu, Shuanghu
    Jiang, Ruoyu
    Liu, Yue
    Zhao, Xue
    Zhou, Guiming
    Xu, Ke
    Meng, Zhaowei
    CLINICAL AND EXPERIMENTAL MEDICINE, 2023, 23 (06) : 2209 - 2220
  • [39]  Single-cell landscape of cancer-associated fibroblasts in immunotherapy resistance of hepatocellular carcinoma
    Wong, Patrick Pak-Chun
    Xiong, Zhewen
    Wu, Haoran
    Chen, Bonan
    To, Ka-Fai
    Chan, Stephen Lam
    Kang, Wei
    Cheng, Alfred Sze-Lok
    GUT, 2023, 72 (SUPPL_1) : A51 - A52
  • [40] Traditional Chinese Medicine to the rescue of allopathic medicine in the co-adjuvant treatment of hepatocellular carcinoma
    Sparkman, Jordan
    Hernaez, Ruben
    El-Serag, Hashem B.
    TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY, 2018, 3